We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$745M
AUM Growth
+$100M
Cap. Flow
+$33.5M
Cap. Flow %
4.49%
Top 10 Hldgs %
32.1%
Holding
165
New
13
Increased
37
Reduced
77
Closed
11

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$4.4M
2
TDC icon
Teradata
TDC
+$3.37M
3
ALB icon
Albemarle
ALB
+$3.15M
4
LNN icon
Lindsay Corp
LNN
+$2.9M
5
CTVA icon
Corteva
CTVA
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 23.6%
2 Technology 23.47%
3 Industrials 19.04%
4 Utilities 16.65%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKH icon
26
Black Hills Corp
BKH
$5.46B
$11M 1.47%
164,300
+59,300
+56% +$3.69M
AQN icon
27
Algonquin Power & Utilities
AQN
$4.44B
$10.5M 1.41%
663,900
+281,900
+74% +$4.65M
TSM icon
28
TSMC
TSM
$2.15T
$10.4M 1.4%
88,069
-3,000
-3% -$372K
NJR icon
29
New Jersey Resources
NJR
$5.59B
$10M 1.34%
251,365
-5,800
-2% -$221K
TEL icon
30
TE Connectivity
TEL
$63.2B
$10M 1.34%
77,584
-2,100
-3% -$270K
POR icon
31
Portland General Electric
POR
$5.79B
$9.65M 1.29%
203,254
+64,954
+47% +$2.84M
MSFT icon
32
Microsoft
MSFT
$3.62T
$9.34M 1.25%
39,620
-725
-2% -$168K
SLB icon
33
SLB Ltd
SLB
$74.1B
$8.56M 1.15%
314,900
+59,500
+23% +$1.57M
TMP icon
34
Tompkins Financial
TMP
$1.45B
$8.3M 1.11%
100,375
-2,550
-2% -$201K
TMO icon
35
Thermo Fisher Scientific
TMO
$214B
$8.28M 1.11%
18,131
-531
-3% -$253K
HON icon
36
Honeywell
HON
$78.6B
$8.23M 1.1%
40,248
-955
-2% -$186K
HZNP
37
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.66M 0.89%
72,327
-3,200
-4% -$270K
ACM icon
38
Aecom
ACM
$9.63B
$6.57M 0.88%
102,417
-35,125
-26% -$2M
MRK icon
39
Merck
MRK
$317B
$6.16M 0.83%
83,759
-944
-1% -$69.6K
CACI icon
40
CACI
CACI
$11.4B
$5.53M 0.74%
22,425
-475
-2% -$114K
GVA icon
41
Granite Construction
GVA
$5.4B
$5.43M 0.73%
134,834
-3,850
-3% -$133K
LITE icon
42
Lumentum
LITE
$64.3B
$5.39M 0.72%
59,048
-3,781
-6% -$350K
AVGO icon
43
Broadcom
AVGO
$1.99T
$5.34M 0.72%
115,150
-1,350
-1% -$62.4K
ASTE icon
44
Astec Industries
ASTE
$1.04B
$4.88M 0.65%
64,730
-1,000
-2% -$67.8K
NXST icon
45
Nexstar Media Group
NXST
$5.8B
$4.71M 0.63%
33,550
-2,100
-6% -$275K
VMW
46
DELISTED
VMware, Inc
VMW
$4.66M 0.62%
30,955
-450
-1% -$64.3K
IDA icon
47
Idacorp
IDA
$8.29B
$4.45M 0.6%
44,509
-500
-1% -$45.7K
EWS icon
48
iShares MSCI Singapore ETF
EWS
$1.05B
$4.24M 0.57%
180,850
-2,500
-1% -$56.1K
DGX icon
49
Quest Diagnostics
DGX
$26B
$3.99M 0.54%
31,102
-14,524
-32% -$1.79M
LFCR icon
50
Lifecore Biomedical
LFCR
$167M
$3.89M 0.52%
367,171
+304
+0.1% +$3.42K

Similar funds

John G. Ullman & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, John G. Ullman & Associates held 165 positions worth $745M, up 16% from $645M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates deployed $33.5M of net new capital in Q1 2021, opening 13 new positions and adding to 37 existing holdings. Its largest new stake was American Tower: 11,570 shares worth $2.77M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Abbott, an estimated $4.4M trimmed.

  • John G. Ullman & Associates's largest Q1 2021 buy was American Tower: 11,570 shares worth $2.77M.
  • John G. Ullman & Associates added most to Verizon in Q1 2021, an estimated $10.3M increase.
  • John G. Ullman & Associates's biggest Q1 2021 reduction was Abbott, cutting an estimated $4.4M.
  • John G. Ullman & Associates fully exited Teradata in Q1 2021, selling an estimated $3.37M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $745M portfolio in Q1 2021.
  • John G. Ullman & Associates opened 13 new positions and closed 11 in Q1 2021.
  • John G. Ullman & Associates's portfolio value rose 16% quarter-over-quarter to $745M.

Based on John G. Ullman & Associates's 13F filing for Q1 2021, filed 22 Apr 2021.